Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Committee Composition

Committee CompositionSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

  Audit Nominating and Corporate Governance Compensation
Raymond W. Cohen Member of Audit Committee Member of Nominating and Corporate Governance Committee Committee Chair for Compensation Committee
Stuart M. Krassner,, ScD, PsyD Member of Audit Committee Committee Chair for Nominating and Corporate Governance Committee Member of Compensation Committee
Luigi Lenaz, MD   Member of Nominating and Corporate Governance Committee Member of Compensation Committee
Anthony E. Maida III,, PhD, MA, MBA Committee Chair for Audit Committee    
Dolatrai M. Vyas, PhD   Member of Nominating and Corporate Governance Committee Member of Compensation Committee
Committee Chair = Chair Committee Member = Member

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
8.02
Change:
- 0.09
Day High:
8.17
Day Low:
8.01
Volume:
398,600
12:15 PM ET on Sep 2, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company